Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Series C round grosses €10mm for to-BBB technologies

Executive Summary

To-BBB technologies BV (uses G-Technology to deliver drug candidates across the blood-brain barrier for brain cancer, stroke, and multiple sclerosis) raised €10mm ($14mm) in Series C financing from new and returning backers.
Deal Industry
  • Biotechnology
    • Liposomes
  • Pharmaceuticals
    • Drug Delivery
      • Site Specific
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

Advertisement
UsernamePublicRestriction

Register